4/A//SEC Filing
Lion Biotechnologies, Inc. 4/A
Accession 0001250853-16-000172
$IOVACIK 0001425205operating
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 3:49 PM ET
Size
7.2 KB
Accession
0001250853-16-000172
Insider Transaction Report
Form 4/AAmended
Hillsberg Sanford
Director
Transactions
- Sale
Common Stock
2016-08-24$9.10/sh−33,500$304,800→ 120,500 total(indirect: By Trust) - Sale
Common Stock
2016-08-25$8.71/sh−20,500$178,612→ 100,000 total(indirect: By Trust)
Footnotes (1)
- [F1]On August 24, 2016, the reporting person mistakenly filed a Form 4 reporting a sale of 54,000 shares of common stock on August 22, 2016, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2016. That sale did not occur on August 22, 2016. Rather, on August 24, 2016, 33,500 shares of common stock were sold pursuant to the Rule 10b5-1 trading plan, and on August 25, 2016, another 20,500 shares of common stock were sold pursuant to that same Rule 10b5-1 trading plan.
Documents
Issuer
Lion Biotechnologies, Inc.
CIK 0001425205
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001425205
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 3:49 PM ET
- Size
- 7.2 KB